LBA9 Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031)-Reference-Cited by-同舟云学术

LBA9 Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031)

Published:2022-09 Issue: Volume:33 Page:S1427
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Parker C.C.,Clarke N.,Cook A.,Catton C.,Cross W.R.,Kynaston H.,Logue J.,Petersen P.M.,Neville P.,Persad R.,Payne H.,Saad F.,Stirling A.,Parulekar W.R.,Parmar M.K.,Sydes M.R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All Biochemical Recurrences Are Equal, but Some Are More Equal than Others;European Urology;2024-09

2. Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047);European Urology;2024-08

3. Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial;European Urology Oncology;2024-07

4. Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-28

5. Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials;Prostate Cancer and Prostatic Diseases;2024-04-08